Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling I Malanchi, H Peinado, D Kassen, T Hussenet, D Metzger, P Chambon, ... Nature 452 (7187), 650, 2008 | 748 | 2008 |
Advances in tenascin-C biology KS Midwood, T Hussenet, B Langlois, G Orend Cellular and molecular life sciences 68 (19), 3175, 2011 | 396 | 2011 |
SOX2 is an oncogene activated by recurrent 3q26. 3 amplifications in human lung squamous cell carcinomas T Hussenet, S Dali, J Exinger, B Monga, B Jost, D Dembelé, N Martinet, ... PLoS One 5 (1), e8960, 2010 | 366 | 2010 |
Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model F Saupe, A Schwenzer, Y Jia, I Gasser, C Spenlé, B Langlois, ... Cell reports 5 (2), 482-492, 2013 | 123 | 2013 |
Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model F Saupe, A Schwenzer, Y Jia, I Gasser, C Spenlé, B Langlois, ... Cell reports 5 (2), 482-492, 2013 | 123 | 2013 |
Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer R Redon, T Hussenet, G Bour, K Caulee, B Jost, D Muller, J Abecassis, ... Cancer research 62 (21), 6211-6217, 2002 | 118 | 2002 |
Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1–Mediated YAP Inhibition Z Sun, A Schwenzer, T Rupp, D Murdamoothoo, R Vegliante, O Lefebvre, ... Cancer research 78 (4), 950-961, 2018 | 114 | 2018 |
SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis T Hussenet, S du Manoir Cell Cycle 9 (8), 1480-1486, 2010 | 112 | 2010 |
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro-and anti-angiogenic signaling T Rupp, B Langlois, MM Koczorowska, A Radwanska, Z Sun, T Hussenet, ... Cell Reports 17 (10), 2607-2619, 2016 | 98 | 2016 |
Tenascin-C increases lung metastasis by impacting blood vessel invasions Z Sun, I Velázquez-Quesada, D Murdamoothoo, C Ahowesso, A Yilmaz, ... Matrix Biology, 2019 | 61 | 2019 |
Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis A Arpel, P Sawma, C Spenlé, J Fritz, L Meyer, N Garnier, ... Cell reports 8 (6), 1714-1721, 2014 | 60 | 2014 |
Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis A Arpel, P Sawma, C Spenlé, J Fritz, L Meyer, N Garnier, ... Cell reports 8 (6), 1714-1721, 2014 | 60 | 2014 |
AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients B Langlois, F Saupe, T Rupp, C Arnold, M Van der Heyden, G Orend, ... Oncotarget 5 (21), 10529, 2014 | 59 | 2014 |
The laminin response in inflammatory bowel disease: protection or malignancy? C Spenle, O Lefebvre, J Lacroute, A Mechine-Neuville, F Barreau, ... PloS one 9 (10), e111336, 2014 | 45 | 2014 |
Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide L Jacob, P Sawma, N Garnier, LAT Meyer, J Fritz, T Hussenet, C Spenlé, ... Oncotarget 7 (36), 57851, 2016 | 44 | 2016 |
Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma D Muller, R Millon, S Théobald, T Hussenet, B Wasylyk, S Du Manoir, ... British journal of cancer 94 (7), 1041, 2006 | 34 | 2006 |
Dysregulation of laminins in intestinal inflammation C Spenlé, T Hussenet, J Lacroute, O Lefebvre, M Kedinger, G Orend, ... Pathologie Biologie 60 (1), 41-47, 2012 | 27 | 2012 |
An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome T Hussenet, D Dembélé, N Martinet, JM Vignaud, S du Manoir Cell Cycle 9 (2), 321-327, 2010 | 19 | 2010 |
Phosphonated chelates for nuclear imaging S Abada, A Lecointre, C Christine, L Ehret-Sabatier, F Saupe, G Orend, ... Organic & biomolecular chemistry 12 (47), 9601-9620, 2014 | 14 | 2014 |
Overlapping 3q28 amplifications in the COMA cell line and undifferentiated primary sarcoma T Hussenet, N Mallem, R Redon, B Jost, A Aurias, S du Manoir Cancer genetics and cytogenetics 169 (2), 102-113, 2006 | 7 | 2006 |